GLP-1 drugs like Ozempic linked to alarming side effect on nails
Newsweek reports on a cross-sectional, self-reported study presented at EADV in Vienna comparing 575 GLP-1 receptor users with 1,329 people with Type 2 diabetes who had never taken the drugs. Nail detachment was reported by 39 percent of users versus 9 percent of controls, and hair loss by 50 percent of users. Associations weakened after adjusting for skin conditions and nutritional deficiencies; authors say causation cannot be inferred.
Why it matters: Relevant to Maryland adults using or considering GLP-1 medications for weight loss or diabetes, and to clinicians who prescribe them or see patients with nail or hair concerns.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to newsweek.com. October 4, 2026.